Your session is about to expire
← Back to Search
Animal-assisted Therapy
Animal-assisted Therapy for Stroke Rehabilitation
N/A
Waitlist Available
Led By Arya Mohabbat, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through inpatient stay, an average of 2 weeks.
Awards & highlights
No Placebo-Only Group
Summary
This trial involves using a specially trained therapy dog during stroke rehabilitation sessions. The target group is patients in the Mayo Clinic Stroke Rehabilitation Unit. The therapy dog aims to improve patients' recovery by making them feel happier, less anxious, and more motivated. Using dogs in therapy has been administered to patients post-stroke to aid in psychological and physical recovery.
Who is the study for?
This trial is for adults over 18 who are currently in the Mayo Clinic's in-patient stroke rehabilitation program. They must have had a stroke, be able to give informed consent, and speak English (as questionnaires are only in English). Pregnant individuals, those with pacemakers, or anyone deemed unsuitable by medical staff cannot participate.
What is being tested?
The study is testing if having a certified therapy dog present during stroke rehabilitative therapy sessions provides additional benefits compared to typical treatment without a therapy dog.
What are the potential side effects?
Since this trial involves animal-assisted therapy rather than medication, there aren't traditional side effects. However, participants might experience allergies or discomfort around dogs.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline through inpatient stay, an average of 2 weeks.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through inpatient stay, an average of 2 weeks.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Anxiety
Change in Depression
Change in Quality of Life Outcomes
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Therapy dog during stroke rehabilitative therapy sessionsExperimental Treatment1 Intervention
Participants randomized to this arm will have a therapy dog present during their stroke rehabilitative therapy sessions.
Group II: No therapy dog during stroke rehabilitative therapy sessionsActive Control1 Intervention
Participants randomized to this arm will have stroke rehabilitative therapy sessions per standard of care with no therapy dog present.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stroke include thrombolytic therapy, which dissolves blood clots to restore blood flow to the brain, and antiplatelet agents, which prevent new clots from forming. Rehabilitation therapies, such as physical, occupational, and speech therapy, are crucial for recovery by helping patients regain lost functions and improve their quality of life.
Animal-assisted therapy, like the use of therapy dogs, can provide additional emotional and psychological support, reducing stress and promoting a positive environment for recovery. This holistic approach is important for stroke patients as it addresses both the physical and emotional aspects of rehabilitation, potentially enhancing overall outcomes.
Find a Location
Who is running the clinical trial?
Purina PetcareUNKNOWN
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,060,971 Total Patients Enrolled
24 Trials studying Stroke
10,927 Patients Enrolled for Stroke
Arya Mohabbat, MDPrincipal InvestigatorMayo Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have experienced a stroke from any reason.You have a pacemaker.
Research Study Groups:
This trial has the following groups:- Group 1: No therapy dog during stroke rehabilitative therapy sessions
- Group 2: Therapy dog during stroke rehabilitative therapy sessions
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.